158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin

E E C de Jong, W Van Elmpt, R T H Leijenaar, H Groen, E Smit, R Boellaard, V Van der Noort, E G C Troost, P Lambin, A-M Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)S126-7
JournalJournal of Thoracic Oncology
Issue number4 Suppl
Publication statusPublished - Apr 2016

Cite this